Catalyst Brief

← Calendar

Readoutin 45d

Novo Nordisk A/S — Insulin icodec

Phase 3 primary completion: A Research Study to See How a Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine, Both in Combination With Insulin Aspart, in Adults With Type 1 Diabetes.

Date
Jan 2027
Type
Readout
Indication
Diabetes Mellitus, Type 1

Source ↗Add to calendar

Get told when this date moves

The weekly brief is free. Pro adds reminders 7 days and 1 day before.

More from Novo Nordisk A/S

  1. May2027
  2. Mar2027